|
Market Closed -
BME
23:35:23 11/09/2026 HKT
|
After hours 02:56:46 | |||
| 57.35 EUR | -0.09% |
|
57.28 | -0.13% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +29.54% | 9 | ||||||
| 1,318.66 | +17.42% | 29 | ||||||
| 277.91 | +4.34% | 22 | ||||||
| 277.31 | +8.75% | 29 | ||||||
| 373.71 | +8.17% | 19 | ||||||
| 154.17 | +11.56% | 22 | ||||||
| 212.3 | +33.47% | 23 | ||||||
| 388.03 | +1.45% | 29 | ||||||
| 310.17 | +8.34% | 23 | ||||||
| 158.15 | +9.21% | 27 | ||||||
| 28.88 | +4.43% | 26 | ||||||
| 569.54 | +10.68% | 26 | ||||||
| 66.42 | +4.18% | 24 | ||||||
| 94.06 | +27.85% | 24 | ||||||
| 21.61 | +21.74% | 21 | ||||||
| 9,323.33 | +45.27% | 15 | ||||||
| 6,603.31 | +16.73% | 16 | ||||||
| 58.22 | +19.55% | 18 | ||||||
| 71.35 | +66.21% | 17 | ||||||
| 41.91 | +15.29% | 11 | ||||||
| Average | 1,021.17 | +18.21% | 22 | ||||||
| Weighted average by Cap. | 712.93 | +13.17% | 25 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
